Dog Vaccines Industry Insights: Market Forecast to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Dog Vaccines Market Expected To Become By 2029 Compared With Its 2025 Level?
The dog vaccines market has exhibited significant expansion in recent years. It is anticipated to increase from $3.61 billion in 2024 to $3.8 billion in 2025, achieving a compound annual growth rate (CAGR) of 5.3%. This past growth can be ascribed to a combination of factors, such as innovative vaccination protocols, increased awareness of zoonotic diseases, widespread globalization and travel, effective educational campaigns, ongoing research and vaccine development, and the continuous evolution of veterinary practice.
The dog vaccines market size is projected to experience robust expansion over the coming years. It is foreseen to achieve a value of $5.05 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.4%. This projected growth can be ascribed to several factors, including increasing pet adoption rates, heightened health consciousness among pet owners, existing government regulations and mandates, the rising humanization of pets, and the continued prevalence of various canine diseases. Significant trends anticipated in this period involve the emergence of pet insurance and healthcare plans, enhanced availability and accessibility of vaccines, the implementation of customized vaccination protocols, shifts in disease patterns, and the development of novel vaccines.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp
Which Major Market Drivers Are Shaping The Future Of The Dog Vaccines Market?
The increasing ownership of pet dogs is anticipated to boost the dog vaccines market. A pet dog is defined as a domesticated or tamed companion animal residing in a household. Dog vaccines are administered as a series of injections to dogs, beginning in puppyhood and continuing throughout their adult lives. These vaccines stimulate the immune system, enabling dogs to combat microorganisms, thereby preventing illness or reducing symptom severity. For example, the National Pet Owners Survey by the American Pet Products Association 2021-2022, a US-based non-profit industry organization, revealed that 70% of households in the United States, equivalent to 90.5 million homes, owned a pet. Among these, 69 million U.S. households kept a dog as a pet, which was the highest number compared to other types of pet animals. Consequently, the growing trend of pet dog adoption is fueling the expansion of the dog vaccines market.
How Is The Dog Vaccines Market Segmented?
The dog vaccines market covered in this report is segmented –
1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines
2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal
3) By Application: Below 6 Months, Above 6 Months
Subsegments:
1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine
2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine
3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine
4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine
5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine
6) By DNA Vaccines: Canine Melanoma Vaccine
7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine
What Trends Are Expected To Drive The Dog Vaccines Market?
Technological advancement represents a significant and growing trend within the dog vaccines market. Key companies operating in this sector are increasingly adopting novel technology for vaccine development. For example, in September 2022, Merck Animal Health, a US-based provider of veterinary pharmaceuticals, vaccines, and technology solutions, introduced Nobivac Intra-Trac Oral BbPi. This product is notable as the first oral vaccine designed with mucosal protection and straightforward oral administration. It is indicated for the vaccination of healthy dogs aged 7 weeks or older to protect against canine parainfluenza virus and Bordetella bronchiseptica. Additionally, the vaccine integrates the innovative Immuno-Mist-R technology developed by Intervet, a subsidiary of Merck & Co. This revolutionary Immuno-Mist-RTM technology is designed to dramatically increase mucosal surface area contact.
Who Are The Key Multinational Companies Dominating The Dog Vaccines Market?
Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Dog Vaccines Market?
Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Dog Vaccines Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8443&type=smp
Browse Through More Reports Similar to the Global Dog Vaccines Market 2025, By The Business Research Company
Veterinary Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-medical-equipment-global-market-report
Veterinary Anesthesia Equipment Global Market Report 2025
Veterinary Patient Monitoring Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
